VitaDAO source record.
This page presents a held funder-owned source excerpt. It does not decide whether any person or project qualifies, should apply, or will receive funding.
Research | VitaDAO
| Funder | VitaDAO |
|---|---|
| Who this may be for | AI-interpreted · not the funder's words The page does not make clear who this is for. Written by a local AI model (qwen3.5:9b-q4_K_M) from the saved page only. It is an interpretation, not a statement by the funder and not eligibility advice. |
| Scope (our category) | Decentralised science & health research (matched words: longevity, biotech, drug discovery, clinical; meaning score 0.743) Assigned by us from the saved page: matched words, a meaning-similarity score, or (marked) an AI tie-break. Not a statement by the funder. |
| Saved page class | programme page Page class describes the saved route only. It does not state whether a programme is open, closed, suitable, available, or an endorsement. |
| Status | VitaDAO is accepting applications for funding through VitaLabs VitaDAO is accepting applications for funding through VitaLabs · saved page text; phrase proposed by a local model and verified verbatim by code |
| Amount | not stated by funder |
| Deadline | not stated by funder |
| Eligibility | not stated by funder |
| Held-source observation | Last material byte change observed 2 days ago · last observed 20260926T223936Z · source signal only |
| Held grant-history observation | No explicit programme-to-dataset mapping with a dated held record is available. This does not state there is no grant history. |
Held source excerpt
JUMP TO: RESOURCES EXPLORE PROJECTS WE OFFER a new model for funding, advancing and commercializing novel therapeutics in an equitable, Permissionless and democratic way. LEARN HOW WE FUND RESEARCH USING IPTs FUNDING IRL SCIENCE ONCHAIN 31 Projects Funded $4.7M Funding Deployed $60.0M Projects FDV 3 Target Discovery Projects 18 Drug Discovery Projects 3 Preclinical Drug Dev Projects 3 Clinical Drug Dev Projects 8 IPTs Generated 3 Companies Founded FUNDING IRL SCIENCE – ONCHAIN 31 Projects Funded $4.7M Funding Deployed $60.0M Projects FDV 3 Target Discovery Projects 18 Drug Discovery Projects 3 Preclinical Drug Dev Projects 3 Clinical Drug Dev Projects 8 IPTs Generated 3 Companies Founded CORE ADVISOR Michael Torres, Ph.D. Advisor Biotech Founder & Drug Developer From the lab bench to the clinic to a Lilly acquisition. $300M CrossBridge Bio Acquired by Eli Lilly $200M+ Raised by ReCode Therapeutics VITARNA Artan Bio CSO VitaDAO IP Token Michael is a rare scientist-founder who takes discoveries off the lab bench and builds them into companies, advancing genetic medicines into the clinic and, with CrossBridge Bio, all the way to a $300M Eli Lilly acquisition. […] the held page continues.
docs_evidence/funding-radar/official-pages/20260926T223936Z/vitadao.html · sha256 974c2e13494b7c78c55e56d5194723a3207da02bb4e0ee54a23fa92542b43069 · saved and fingerprinted 20260926T223936Z · direct download of the public page · held page title and funding-related excerpt
Open funder link labelled “LEARN MORE & APPLY” →
saved page anchor text containing apply/application/submit
The funder statement is retrieved evidence only. Held-source observation is a byte-change signal only. Neither signal determines eligibility, fit, application strength, likely outcome, or programme availability.